Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00762008 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv17
  2. Primary and study completion dates: Sep 2025 to Dec 2027v16
  3. Primary and study completion dates: Sep 2022 to Sep 2025v15
  4. Primary and study completion dates: Dec 2020 to Sep 2022v14
  5. 3 versions Re-verified since Feb 6, 2018, no change to tracked fieldsv11-v13
Show 9 earlier versionsHide 9 earlier versions
  1. Enrollment target: 250 to 500
    • Primary and study completion dates: Dec 2015 to Dec 2020
    v10
  2. Re-verified, no change to tracked fieldsv9
  3. Primary and study completion dates: Dec 2012 to Dec 2015v8
  4. Re-verified, no change to tracked fieldsv7
  5. Eligibility criteria expanded, about 13 wordsv6
  6. Re-verified, no change to tracked fieldsv5
  7. Primary and study completion dates: Dec 2010 to Dec 2012v4
  8. Collaborators expanded, about 5 wordsv3
  9. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
UConn Health
38 trials monitored
See 2 trials at risk
Heart Disease
8,786 trials monitored
See 412 trials at risk
Heart Failure
1,995 trials monitored
See 111 trials at risk
The purpose of this research is to determine if two proteins in the blood are increased during acute heart failure. These two proteins are produced when the heart becomes dysfunctional and unable to contract normally. They may then be released into the blood and be detected by standard method in the research laboratory. Thus, the purpose of this study is to determine the relation between the change of these two proteins in the blood and the occurrence of acute heart failure. At this time, detection of an increase in these proteins in the blood is not known to be associated with any disease or heart failure.
Trial Details
NCT Number NCT00762008
Lead Sponsor UConn Health
Collaborators: CT Department of Public Health
Conditions
(from sponsor)		 Acute Decompensated Heart Failure, Heart Failure
Related terms Heart Failure
Enrollment 500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov